5:18 PM
 | 
May 16, 2014
 |  BC Extra  |  Company News

Shire forms ophthalmic unit, to submit lifitegrast NDA

Shire plc (LSE:SHP; NASDAQ:SHPG) formed a business unit to commercialize its ophthalmic products and said it plans to submit an NDA to FDA for lifitegrast to treat dry eye disease in 1Q15. The submission timeline update came after the company met with FDA to discuss the...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >